Is Keryx Biopharmaceuticals (KERX) Going to Burn These Hedge Funds?

Page 1 of 2

Keryx Biopharmaceuticals (NASDAQ:KERX) was in 6 hedge funds’ portfolio at the end of December. KERX investors should pay attention to a decrease in support from the world’s most elite money managers of late. There were 7 hedge funds in our database with KERX positions at the end of the previous quarter.

In the 21st century investor’s toolkit, there are a multitude of metrics investors can use to analyze their holdings. A duo of the most under-the-radar are hedge fund and insider trading interest. At Insider Monkey, our studies have shown that, historically, those who follow the top picks of the elite money managers can trounce the S&P 500 by a solid amount (see just how much).

Keryx Biopharmaceuticals (NASDAQ:KERX)

Just as key, bullish insider trading activity is another way to break down the stock market universe. Just as you’d expect, there are lots of reasons for an insider to sell shares of his or her company, but only one, very clear reason why they would behave bullishly. Many academic studies have demonstrated the useful potential of this tactic if you understand what to do (learn more here).

With all of this in mind, we’re going to take a glance at the recent action encompassing Keryx Biopharmaceuticals (NASDAQ:KERX).

What does the smart money think about Keryx Biopharmaceuticals (NASDAQ:KERX)?

Heading into 2013, a total of 6 of the hedge funds we track held long positions in this stock, a change of -14% from the third quarter. With hedgies’ capital changing hands, there exists a few key hedge fund managers who were boosting their stakes significantly.

According to our comprehensive database, Joseph Edelman’s Perceptive Advisors had the largest position in Keryx Biopharmaceuticals (NASDAQ:KERX), worth close to $3 million, accounting for 0.5% of its total 13F portfolio. Coming in second is Israel Englander of Millennium Management, with a $0.7 million position; less than 0.1%% of its 13F portfolio is allocated to the company. Other hedge funds that hold long positions include D. E. Shaw’s D E Shaw, and Cliff Asness’s AQR Capital Management.

Since Keryx Biopharmaceuticals (NASDAQ:KERX) has faced falling interest from the aggregate hedge fund industry, we can see that there were a few hedge funds that slashed their positions entirely at the end of the year. Intriguingly, John Burbank’s Passport Capital cut the largest position of the “upper crust” of funds we monitor, worth about $1.4 million in stock.. Chuck Royce’s fund, Royce & Associates, also cut its stock, about $0.7 million worth. These bearish behaviors are intriguing to say the least, as total hedge fund interest fell by 1 funds at the end of the year.

How are insiders trading Keryx Biopharmaceuticals (NASDAQ:KERX)?

Insider buying is most useful when the company in question has experienced transactions within the past 180 days. Over the last half-year time period, Keryx Biopharmaceuticals (NASDAQ:KERX) has seen zero unique insiders purchasing, and 2 insider sales (see the details of insider trades here).

Let’s also take a look at hedge fund and insider activity in other stocks similar to Keryx Biopharmaceuticals (NASDAQ:KERX). These stocks are Astex Pharmaceuticals, Inc. (NASDAQ:ASTX), Kythera Biopharmaceuticals Inc (NASDAQ:KYTH), Endocyte, Inc. (NASDAQ:ECYT), Intercept Pharmaceuticals Inc (NASDAQ:ICPT), and Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL). This group of stocks are in the drug manufacturers – major industry and their market caps resemble KERX’s market cap.

Page 1 of 2
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The 8 Best Foods for Gaining Weight

The 10 Most Expensive Colleges in the World

The 7 Most Memorable Ad Campaigns of All Time

The 7 Most Expensive High Schools in the World

The 10 Electric Vehicles with the Longest Range

The 10 Cities with the Worst Drivers in the World

The 10 Most Expensive Dresses Ever Created

10 Islands to Visit Before You Die

10 Famous Celebrities Who Needed Rehab

The 15 Countries with the Largest Oil Reserves

The 10 Most Overused Excuses in the World

The 5 Best iOS Apps You Can’t Get on Android

5 Companies Damaged By Social Media Blunders

The 10 Most Legendary Blues Songs

The 10 Most Lawless Places in the World

4 Reasons China is a Threat to the US

The 17 Most Sugary Drinks in the World

The 10 Most Ruthless Rulers in History

The 10 Greatest Generals in History

Top 8 Travel Destinations for 2015

The 10 Safest Dog Breeds for Children

The 10 Most Stolen Vehicles in the US

The 7 Most Expensive Celebrity Weddings

The 10 Best LoL Teams in the World

Top 10 Worst Marketing Campaigns Ever Produced

Top 5 Diets that Help You Lose Weight

The 10 Best Ways to Stay Awake

7 Artists That Switched Musical Genres

The 10 Most Expensive Cities to Live in New Jersey

The 10 Best High Schools in New York

The 10 Countries With the Least Gender Inequality

The 6 Biggest Musician-Manager Feuds

The 10 Countries with the Cheapest Gas Prices

The 7 Most Theatrical Bands of All Time

The 8 Worst Band Breakups of All Time

The 10 Most Important South American Leaders

The 7 Most Successful Casting Show Winners

The 10 Most Peaceful Countries in the World

5 Big Reasons Communism Failed

The 15 Most Famous Carl Icahn Quotes

10 Scary Animals that are Actually Harmless

The 8 Most Famous Singer-Actors in Entertainment

The 10 Longest Wars of All Time

The 13 Worst Looking Foods that Taste Great

The 6 Most Gruesome Injuries Suffered During a Sports Match

The 20 Biggest Contracts in MLB History

The 7 Worst Blown Calls in Sports History

7 Free Ways to Advertise Your Business Online

The 18 Best R&B Songs of the 90’s

The 10 Most Dangerous States to be a Cop

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!